In Brief: NMC's Hampers
This article was originally published in The Gray Sheet
NMC's Hampers: National Medical Care Chairman, President and CEO Constantine Hampers resigns from his position at the dialysis device company, as well as his posts of director and executive VP for NMC parent W.R. Grace. Hampers, who founded NMC in 1968, will remain as an advisor to the company "on certain international business development opportunities," according to a Grace release. An "executive committee" of NMC and Grace managers will oversee operations at NMC until completion of the firm's acquisition by German dialysis firm Fresenius AG. The $2.3 bil. deal, for which a definitive agreement was signed in early February ("The Gray Sheet" Feb. 12, p. 8), is expected to close in August...
You may also be interested in...
Celltrion has announced plans to add a third biopharmaceutical facility and a new global biotechnology research center at the Korean firm’s existing site in Songdo, Incheon, as the firm also revealed record third-quarter financial results.
An upturn in M&A activity across the whole healthcare sector is expected in 2021, with the COVID-19 pandemic and the associated development of a vaccine shining a light on the sector, says a recent survey by Jefferies.
Australian patients with phototoxicity due to the rare condition EPP will now have their first treatment option – provided the drug's developer, Clinuvel, secures reimbursement under the Pharmaceutical Benefits Scheme.